Zalmox-BR Eye Drops

MRP :

130.00

Category

ZALMOX-BR Eye Drops combine Moxifloxacin 0.5% and Bromfenac Sodium 0.09%, the banishing force for pre and post-operative conditions and CME (Cystoid Macular Edema) prevention. Manufactured in India under WHO-GMP standards. Bulk and export enquiries welcome.

Composition & Packing

CompositionMoxifloxacin 0.5% w/v + Bromfenac Sodium 0.09% w/v + Benzalkonium Chloride Solution IP 0.02% v/v
Packing5ml
Facebook
Twitter
LinkedIn

About ZALMOX-BR Eye Drops

ZALMOX-BR Eye Drops combine Moxifloxacin 0.5% and Bromfenac Sodium 0.09%, formulated as the banishing force for pre and post-operative conditions and CME. This is a preferred drug to prevent and treat Cystoid Macular Edema (CME) after cataract surgery without adverse effect. ZALMOX-BR is manufactured by I Smith at our WHO-GMP certified facility in Baddi, Himachal Pradesh, for supply to hospitals, retail pharmacies, and export partners.

How It Works

  • Moxifloxacin — a smart broad-spectrum antibiotic
  • Bromfenac — suppresses anterior chamber inflammation

Indications

  • Pre and post-operative ocular conditions
  • Prevention and treatment of Cystoid Macular Edema (CME) after cataract surgery

How ZALMOX-BR Differs from Other ZALMOX Combinations

ZALMOX-BR pairs Moxifloxacin with Bromfenac, an NSAID specifically positioned as a preferred drug for CME prevention after cataract surgery. This differs from ZALMOX-D, ZALMOX-P, and ZALMOX-LP, which pair Moxifloxacin with corticosteroids for broader post-surgical inflammation control, and ZALMOX-TM, which pairs it with Tobramycin for antibacterial-only coverage.

Why Source ZALMOX-BR from I Smith

  • WHO-GMP certified manufacturing unit in Baddi, Himachal Pradesh
  • Competitive bulk and wholesale pricing
  • Consistent batch quality with full documentation support
  • Third-party / contract manufacturing available
  • Pan-India and export supply capability

Frequently Asked Questions

What is ZALMOX-BR Eye Drops used for?
It is used in pre and post-operative ocular conditions, and is preferred for the prevention and treatment of Cystoid Macular Edema (CME) after cataract surgery.

What is CME and why does it matter after cataract surgery?
Cystoid Macular Edema (CME) is a form of retinal swelling that can occur after cataract surgery. Bromfenac’s anterior chamber anti-inflammatory action makes ZALMOX-BR a preferred choice for preventing and treating CME without adverse effect.

What is the composition and packing of ZALMOX-BR Eye Drops?
Each ml contains Moxifloxacin 0.5% w/v, Bromfenac Sodium 0.09% w/v, and Benzalkonium Chloride Solution IP 0.02% v/v, in a 5ml bottle.

Is ZALMOX-BR available for bulk or export orders?
Yes, I Smith supplies ZALMOX-BR Eye Drops in bulk for domestic distribution and export, along with third-party manufacturing options.

Bulk Order & Manufacturing Enquiry

Looking to buy ZALMOX-BR Eye Drops in bulk, become a distribution or export partner, or explore third-party manufacturing? Share your requirement and our team will respond with pricing, MOQ, and product documentation.

Brand

ismith

Composition

Moxifloxacin 0.5% W/v + Bromfenac Sodium 0.09% W/v Benzalkonium Chloride Solution IP 0.02% V/v

Pack Size

5ML

Pack Type

NA

Scroll to Top
LET'S TALK
Contact Us & Get In Touch here !